A detailed history of Altfest L J & CO Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Altfest L J & CO Inc holds 1,643 shares of VRTX stock, worth $740,943. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,643
Previous 1,472 11.62%
Holding current value
$740,943
Previous $690,000 10.72%
% of portfolio
0.1%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$460.0 - $505.78 $78,660 - $86,488
171 Added 11.62%
1,643 $764,000
Q2 2024

Aug 07, 2024

BUY
$392.81 - $485.53 $13,748 - $16,993
35 Added 2.44%
1,472 $690,000
Q1 2024

Apr 22, 2024

BUY
$407.69 - $446.08 $2,038 - $2,230
5 Added 0.35%
1,437 $601,000
Q4 2023

Jan 18, 2024

SELL
$343.0 - $410.68 $6,174 - $7,392
-18 Reduced 1.24%
1,432 $583,000
Q3 2023

Oct 26, 2023

SELL
$338.18 - $362.46 $27,730 - $29,721
-82 Reduced 5.35%
1,450 $504,000
Q2 2023

Aug 09, 2023

BUY
$314.42 - $351.91 $23,895 - $26,745
76 Added 5.22%
1,532 $539,000
Q1 2023

Apr 20, 2023

BUY
$283.23 - $323.1 $49,848 - $56,865
176 Added 13.75%
1,456 $459,000
Q4 2022

Feb 02, 2023

SELL
$285.76 - $321.48 $335,768 - $377,739
-1,175 Reduced 47.86%
1,280 $370,000
Q3 2022

Nov 15, 2022

SELL
$273.83 - $305.53 $821 - $916
-3 Reduced 0.12%
2,455 $711,000
Q2 2022

Aug 04, 2022

SELL
$234.96 - $292.55 $133,692 - $166,460
-569 Reduced 18.8%
2,458 $693,000
Q1 2022

May 02, 2022

BUY
$221.42 - $260.97 $17,935 - $21,138
81 Added 2.75%
3,027 $790,000
Q4 2021

Jan 24, 2022

SELL
$177.01 - $223.45 $2,655 - $3,351
-15 Reduced 0.51%
2,946 $647,000
Q3 2021

Oct 12, 2021

BUY
$181.39 - $202.99 $212,226 - $237,498
1,170 Added 65.33%
2,961 $537,000
Q2 2021

Jul 28, 2021

BUY
$187.49 - $221.1 $40,497 - $47,757
216 Added 13.71%
1,791 $361,000
Q1 2021

May 07, 2021

BUY
$207.02 - $241.31 $4,554 - $5,308
22 Added 1.42%
1,575 $338,000
Q4 2020

Jan 21, 2021

BUY
$207.01 - $276.09 $321,486 - $428,767
1,553 New
1,553 $367,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Altfest L J & CO Inc Portfolio

Follow Altfest L J & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.